483
Northland Nuclear Medicine, LLCNorthland Nuclear Medicine, LLC – FDA 483, Jun 7, 2019
Record Details
An FDA inspection of Northland Nuclear Medicine, LLC in Bismarck, ND, a manufacturer of PET drugs, revealed significant deficiencies. The firm lacked adequate production and process controls, including issues with aseptic process simulations, data integrity, and vendor qualification. Additionally, critical equipment was not properly qualified, and master production records were incomplete, raising concerns about the consistent quality and purity of their 18F-FDG product.
View Company Profile
ID · 7a92875d-0ef0-44bc-b02c-acbc7e748a4c
Other documents for Northland Nuclear Medicine, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.